Unlocking Opportunities in the Antiparasitic Drugs Market: 2025-2034 Forecast Report

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Antiparasitic Drugs Industry Market Size Be by 2025?
The market of antiparasitic drugs has seen significant expansion in the past few years. It is expected to evolve from $24.06 billion in 2024 to $25.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. The growth witnessed in the historic period is due to factors such as prevalence of parasitic infections, resistance to current treatments, and international health initiatives.

What's the Long-Term Growth Forecast for the Antiparasitic Drugs Market Size Through 2029?
The market size for antiparasitic drugs is anticipated to experience robust expansion in the foroming years, reaching "$33.29 billion by 2029 with a compounded annual growth rate (CAGR) of 6.8%. This growth in the forecast period can be credited to the rise of parasitic threats, climatic alterations and diseases transmitted by vectors, amplified focus on worldwide health safety, and healare accessibility. Noteworthy trends in the predicted period encompass advancements in medication formulation, specialized treatments, combined therapies, collaborations between public and private sectors, telemedicine, and distant diagnosis.

View the full report here:
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report

What Are the Key Growth Drivers Fueling the Antiparasitic Drugs Market Expansion?
The rise in vector-borne diseases is predicted to spur the expansion of the antiparasitic drugs market. These diseases, spread to humans or other animals via insect bites from organisms such as mosquitoes, ticks, and flies, include examples like malaria, dengue, and yellow fever. Antiparasitic drugs are vital in halting the proliferation of these diseases, as they target and eliminate the culpable parasites. Chloroquine, doxycycline, and atovaquone-proguanil represent a few antiparasitic drugs popularly employed in malaria treatment. For example, the US-based governmental agency, Centers for Disease Control and Prevention reported in June 2024 that, from January to June 2024, over 9.7 million dengue cases were tracked in the Americas, a figure more than twice the 4.6 million cases documented in 2023. Puerto Rico reported 1,498 dengue instances in the United States, and 745 cases were traced back to U.S. travelers returning from impacted regions. Consequently, the rising occurrence of vector-borne diseases is fuelling the growth of the antiparasitic drugs market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12927&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Antiparasitic Drugs Market?
Leading corporations in the antiparasitic drugs sector are focusing their efforts on producing innovative solutions, such as easy-to-give chewable veterinary medications to improve pet compliance. These chewable veterinary goods are flavorful, simple to administer tablets or treats that deliver medicine to animals, thereby enhancing pet cooperation by making the treatment more appetizing and stress-free. For instance, C.H. Boehringer Sohn AG and Co. KG, a pharmaceutical company based in Germany, unveiled NexGard Spectra in April 2024 to provide all-inclusive parasite control. NexGard SPECTRA, a delectable soft chew, offers thorough internal and external parasite control for dogs in one monthly dose, effectively combating fleas, ticks, heartworms, and various gut worms. It exhibits quick action, eliminating fleas within four hours of administration and delivering over 99% efficacy against multiple parasites shortly after.

How Is the Antiparasitic Drugs Market Segmented?
The antiparasitic drugs market covered in this report is segmented -

1) By Product Type: Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products
2) By Treatment: Avermectins, Bezimidazoles, Pyrimidines, Organophosphates, Imidazolesthiazoles
3) By Route of Administration: Oral, Injectable, Topical
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:
1) By Anthelmintics: Benzimidazoles, Ivermectin, Pyrantel Pamoate, Praziquantel
2) By Antiprotozoals: Metronidazole, Tinidazole, Nitazoxanide, Pentamidine
3) By Ectoparasiticides: Permethrin, Malathion, Lindane, Fipronil
4) By Other Products: Combination Antiparasitic Drugs, Novel Antiparasitic Agents

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12927&type=smp

Which Companies Are Leading the Charge in Antiparasitic Drugs Market Innovation?
Major companies operating in the antiparasitic drugs market are Pfizer Inc., Johnson & Johnson, Cadila Pharmaceuticals, Merck & Co.Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim group, Zoetis Inc., Eisai Co. Ltd., Covetrus Inc., IDEXX Laboratories Inc., Dr. Reddy's Laboratories, Intas Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ceva Sante Animale S.A., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Mankind Pharma, Neogen Corporation, Bimeda Inc., Indoco Remedies Ltd., ECO Animal Health, Lincoln Pharmaceuticals Ltd., Laboratorios Calier.

Which Regions Are Leading the Global Antiparasitic Drugs Market in Revenue?
North America was the largest region in the antiparasitic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antiparasitic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12927

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.